Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


29.04.2024

1 Am J Clin Pathol
3 Am J Hematol
2 Ann Hematol
4 Blood
2 BMC Cancer
6 Eur J Haematol
1 Genes Chromosomes Cancer
1 J Pediatr Hematol Oncol
8 Leuk Lymphoma
1 Leukemia
2 N Engl J Med


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. BRAR N, Lawrence L, Fung E, Zehnder JL, et al
    p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes.
    Am J Clin Pathol. 2024 Apr 20:aqae034. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  2. YE Y, Labopin M, Gerard S, Yakoub-Agha I, et al
    Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the Europea
    Am J Hematol. 2024 Apr 24. doi: 10.1002/ajh.27342.
    PubMed         Abstract available

  3. ZHOU Z, Zhuo N, Zhou Y, Sun C, et al
    Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
    Am J Hematol. 2024 Apr 23. doi: 10.1002/ajh.27340.
    PubMed        

  4. SZUBER N, Orazi A, Tefferi A
    Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Am J Hematol. 2024 Apr 21. doi: 10.1002/ajh.27321.
    PubMed         Abstract available


    Ann Hematol

  5. TAZOE K, Harada N, Makuuchi Y, Kuno M, et al
    Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Ann Hematol. 2024 Apr 25. doi: 10.1007/s00277-024-05772.
    PubMed         Abstract available

  6. BENCHIKH S, Charlene SSG, Bousfiha A, Razoki L, et al
    Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco.
    Ann Hematol. 2024 Apr 24. doi: 10.1007/s00277-024-05747.
    PubMed         Abstract available


    Blood

  7. WIENECKE CP, Heida B, Venturini L, Gabdoulline R, et al
    Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation.
    Blood. 2024 Apr 26:blood.2023022697. doi: 10.1182/blood.2023022697.
    PubMed         Abstract available

  8. SUBKLEWE M
    T cells take aim in AML: targeting IDH2.
    Blood. 2024;143:1681-1682.
    PubMed        

  9. TRAN TH, Tasian SK
    How I Treat Philadelphia Chromosome-like Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults.
    Blood. 2024 Apr 24:blood.2023023153. doi: 10.1182/blood.2023023153.
    PubMed         Abstract available

  10. ABDELBAKY SB, Giacopelli B, Rabe KG, Yamaguchi K, et al
    Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
    Blood. 2024;143:1752-1757.
    PubMed         Abstract available


    BMC Cancer

  11. URGESSA F, Lengiso B, Tsegaye A, Gebremedhin A, et al
    Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study.
    BMC Cancer. 2024;24:530.
    PubMed         Abstract available

  12. QIU Y, Bai L, Zhao H, Mei X, et al
    Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.
    BMC Cancer. 2024;24:520.
    PubMed         Abstract available


    Eur J Haematol

  13. KUTSCH N, Godel P, Voltin CA, Hallek M, et al
    Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.
    Eur J Haematol. 2024;112:984-987.
    PubMed         Abstract available

  14. GERHARDT A, Dorfel S, Schulz H, Schlag R, et al
    Outcomes with ibrutinib in patients with chronic lymphocytic leukaemia: Results from the German multicentre REALITY study.
    Eur J Haematol. 2024;112:927-937.
    PubMed         Abstract available

  15. SKIPPER MT, Birkebaek N, Jensen RB, Rank CU, et al
    Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
    Eur J Haematol. 2024;112:944-956.
    PubMed         Abstract available

  16. MIKLOS E, Oliver TP, Adam K, Eva K, et al
    Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients.
    Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14213.
    PubMed         Abstract available

  17. MARRA JD, Galli E, Giammarco S, Metafuni E, et al
    CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation.
    Eur J Haematol. 2024 Apr 21. doi: 10.1111/ejh.14217.
    PubMed         Abstract available

  18. AFTANDILIAN C, Bito XR, Berman D, Zhang A, et al
    Plasma microbial cell-free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia.
    Eur J Haematol. 2024 Apr 24. doi: 10.1111/ejh.14216.
    PubMed         Abstract available


    Genes Chromosomes Cancer

  19. MAVRIDOU E, Lema Fernandez AG, Nardelli C, Pierini V, et al
    A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
    Genes Chromosomes Cancer. 2024;63:e23235.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  20. LI Y, Hu GH, Xu LP, Zhang XH, et al
    CAR-T Therapy Followed by Hematopoietic Stem Cell Transplantation Can Improve Survival in Children Relapsed/Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2024 Apr 23. doi: 10.1097/MPH.0000000000002861.
    PubMed         Abstract available


    Leuk Lymphoma

  21. NESR G, Claudiani S, Milojkovic D, Innes A, et al
    Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.
    Leuk Lymphoma. 2024 Apr 23:1-6. doi: 10.1080/10428194.2024.2343758.
    PubMed         Abstract available

  22. STEMPEL JM, Shallis RM, Wong R, Podoltsev NA, et al
    Challenges in management of older patients with chronic myeloid leukemia.
    Leuk Lymphoma. 2024 Apr 23:1-14. doi: 10.1080/10428194.2024.2342559.
    PubMed         Abstract available

  23. BEWERSDORF JP, Patel KK, Shallis RM, Podoltsev NA, et al
    Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia.
    Leuk Lymphoma. 2024 Apr 22:1-9. doi: 10.1080/10428194.2024.2344052.
    PubMed         Abstract available

  24. FLECK C, Karabinos A, Cook A, Moore DC, et al
    Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia.
    Leuk Lymphoma. 2024 Apr 22:1-2. doi: 10.1080/10428194.2024.2341999.
    PubMed        

  25. ROGERS KA, Thompson PA
    Pairing obinutuzumab with venetoclax in relapsed CLL.
    Leuk Lymphoma. 2024;65:543-545.
    PubMed        

  26. GARCIAZ S, Berton G, Hospital MA, Guille A, et al
    Long-term survival of NPM1 AML treated with intensive chemotherapy with extensive molecular data available.
    Leuk Lymphoma. 2024;65:700-703.
    PubMed        

  27. OKABE S, Moriyama M, Gotoh A
    Effects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive cells.
    Leuk Lymphoma. 2024;65:696-699.
    PubMed        

  28. FATIMA N, Shen Y, Crassini K, Burling O, et al
    The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.
    Leuk Lymphoma. 2024;65:585-597.
    PubMed         Abstract available


    Leukemia

  29. GUO J, Buettner R, Du L, Li Z, et al
    8-Cl-Ado and 8-NH(2)-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia.
    Leukemia. 2024 Apr 20. doi: 10.1038/s41375-024-02222.
    PubMed         Abstract available


    N Engl J Med

  30. BLAISE D
    CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.
    N Engl J Med. 2024;390:1526-1527.
    PubMed        

  31. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.